HEOR News Roundup

Tuesday, February 4, 2020 | Issue 487

Subscribe Contact Advertise HEOR & RWE Marketplace

Sponsored by

CVS Caremark Plan Looks
to Nix Costs for Diabetes Drugs

CVS Caremark’s newest option, RxZERO, looks to nix out-of-pocket costs for diabetes drugs through a number of strategies, including nudging employers and plan sponsors to cheaper generic drugs, Fierce Healthcare reports.

Read More

Denmark Adopting QALY System for Hospital Drugs

New Guidance Enables States to Convert Medicaid Funding into Block Grant

NICE Rejects Coverage of J&J’s Spravato

ICER Hosts Meeting on Migraine Treatments




11th Annual Medicaid Innovations Forum

February 5-7 | Orlando, Florida




FirstMedCommsJob: In conversation with the account managers

February 5

Syndicated Reports
2019 Healthcare Benchmarks: Social Determinants of Health
Pricing Transparency in Pharma
White Papers
Developing medical communications specifically for nurses
Protocol Design in Real-World Evidence: The Indispensable Link Between Strategic Need and Study Execution
  Senior Director & Asia Pacific Practice Lead (Market Access) Principal / Senior Principal (Market Access) Senior Consultant / Associate Director (Market Access) Medical Writer – Boston  

Share this newsletter!